Efficacy and Safety of Travoprost 0.004% Versus Tafluprost 0.0015% in Patients With Primary Open-angle Glaucoma or Ocular Hypertension
Condition(s):GlaucomaLast Updated:June 20, 2012Completed
Hide Studies Not Open or Pending
Condition(s):GlaucomaLast Updated:June 20, 2012Completed
Condition(s):Primary Open Angle GlaucomaLast Updated:July 28, 2016Completed
Condition(s):GlaucomaLast Updated:May 12, 2014Completed
Condition(s):Open Angle Glaucoma; Ocular HypertensionLast Updated:September 29, 2023Recruiting
Condition(s):Open Angle Glaucoma; Ocular HypertensionLast Updated:February 10, 2012Withdrawn
Condition(s):Open-Angle Glaucoma; Ocular HypertensionLast Updated:May 15, 2013Terminated
Condition(s):GlaucomaLast Updated:December 12, 2019Completed
Condition(s):Ocular Hypertension; Primary GlaucomaLast Updated:May 27, 2011Unknown status
Condition(s):Neovascular GlaucomaLast Updated:June 22, 2011Withdrawn
Condition(s):Ocular Hypertension; Open-angle GlaucomaLast Updated:July 10, 2014Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.